Home > Boards > US Listed > Biotechs > Applied DNA Sciences Inc. (APDN)

VOTE_EARLY_VOTE_OFTEN VOTE_DOWN PROPOSAL 1 REVERSE SPLIT BEFORE SHARE

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mcsharkey Member Profile
 
Followed By 21
Posts 6,799
Boards Moderated 1
Alias Born 05/14/11
160x600 placeholder
Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/15/2019 12:08:00 PM
Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/13/2019 9:20:00 AM
Registration of Additional Securities (up to 20%) (s-1mef) Edgar (US Regulatory) - 11/13/2019 9:13:26 AM
Successful DNA Tagging of Leather at One of the World’s Largest Tanneries Business Wire - 11/12/2019 9:03:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 4:17:47 PM
Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors  Business Wire - 11/8/2019 3:22:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/8/2019 3:15:19 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/1/2019 5:22:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 4:07:01 PM
Applied DNA Sciences Announces 1-For-40 Reverse Stock Split Business Wire - 10/31/2019 1:00:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 10/25/2019 4:28:35 PM
Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials Business Wire - 10/22/2019 8:30:00 AM
Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance Business Wire - 10/16/2019 5:30:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/8/2019 4:02:30 PM
Molecular Tagging of Pharmaceutical Excipients Utilizing Applied DNA’s Technology Published in Peer-Reviewed Journal Business Wire - 10/4/2019 5:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 10/3/2019 4:03:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:32:21 AM
Applied DNA Receives Extension from Nasdaq Business Wire - 10/3/2019 5:00:00 AM
LineaRx’s iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over PSA as a Biomarker in Pros... Business Wire - 10/1/2019 8:30:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 9/26/2019 5:23:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/25/2019 4:03:37 PM
Applied DNA Receives $1 Million Order to Supply SigNature® T Molecular Taggant for 2019-2020 Cotton Harvest Season Business Wire - 9/24/2019 9:00:00 AM
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction Business Wire - 9/19/2019 4:00:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 9/18/2019 5:30:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2019 4:02:08 PM
mcsharkey   Monday, 10/07/19 02:38:42 PM
Re: None
Post # of 56949 
VOTE_EARLY_VOTE_OFTEN VOTE_DOWN PROPOSAL 1 REVERSE SPLIT BEFORE SHARE HOLDERS MEETING, VOTE FOR PROPOSAL 2

DAMN. didn't get the ballot from US Postal Service today. I'm against proposal 1. It does have an actional provision I favor but PROVISION 2 has to pass....

Quote:
PROPOSAL 1
Way down in section on REVERSE SPLIT RATIO, listed as being on page 9 and the LINK. I'm voting against the whole proposal.

TO APPROVE THE AMENDMENT TO THE COMPANY’S CERTIFICATE OF INCORPORATION EFFECTING THE REVERSE STOCK SPLIT IN THE RANGE FROM ONE-FOR-FIFTEEN TO ONE-FOR-FIFTY.
on page -9-
The Board will have sole discretion as to any implementation of, and the exact timing and actual Reverse Stock Split Ratio of, the Reverse Stock Split within the range of Reverse Stock Split Ratios specified in this proposal and before December 31, 2019. The Board may also determine that the Reverse Stock Split is no longer in the best interests of the Company and its stockholders and decide to abandon the Reverse Stock Split at any time before, during or after the Special Meeting and prior to its effectiveness, without further action by the stockholders.



On this second proposal, we have these provisions I favor.

And PARKMART, Hayward is more than pretty good at extending our LISTING ON NASDAQ. Asking you ALL to consider this extending action:
Quote:
PROPOSAL 2
APPROVAL OF THE ADJOURNMENT OF THE SPECIAL MEETING TO SOLICIT ADDITIONAL PROXIES
LINK to second
Adjournment of the Special Meeting

In the event that the number of shares of our common stock present in person or represented by proxy at the Special Meeting and voting “FOR” the adoption of the Reverse Stock Split is insufficient to adopt the Reverse Stock Split, we may move to adjourn the Special Meeting in order to enable the Board to solicit additional proxies in favor of the adoption of the Reverse Stock Split. In that event, we will ask stockholders to vote only upon this Proposal 2 and not on Proposal 1. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.

If a quorum is present, Proposal 2, approval of the proposal to adjourn the Special Meeting to a later date, requires the affirmative vote of the majority of the votes cast on the proposal. Abstentions and broker non-votes will not be considered votes cast on Proposal 2 and will therefore not have any effect with respect to Proposal 2.

The Board Recommends a Vote FOR the Adjournment of the Special Meeting to Solicit Additional Proxies if there Are Insufficient Proxies at the Special Meeting to Approve the Reverse Stock Split. Proxies that Are Returned Will Be so Voted Unless Otherwise Instructed.


Vote now for PROVISION 2
GLTUA

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist